SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. B. Turner, D. Zabetakis, E. R. Goldman, G. P. Anderson, Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection, Protein Engineering Design and Selection, 2014, 27, 3, 89

    CrossRef

  2. 2
    Isabel Fofana, Nikolaus Jilg, Raymond T. Chung, Thomas F. Baumert, Entry inhibitors and future treatment of hepatitis C, Antiviral Research, 2014, 104, 136

    CrossRef

  3. 3
    Thomas F Baumert, Luke Meredith, Yi Ni, Daniel J Felmlee, Jane A McKeating, Stephan Urban, Entry of hepatitis B and C viruses — recent progress and future impact, Current Opinion in Virology, 2014, 4, 58

    CrossRef

  4. 4
    Jonathan K. Ball, Alexander W. Tarr, Jane A. McKeating, The past, present and future of neutralizing antibodies for hepatitis C virus, Antiviral Research, 2014, 105, 100

    CrossRef

  5. 5
    Lok Man John Law, Abdolamir Landi, Wendy C Magee, D Lorne Tyrrell, Michael Houghton, Progress towards a hepatitis C virus vaccine, Emerging Microbes & Infections, 2013, 2, 11, e79

    CrossRef

  6. 6
    Giuseppe Sautto, Alexander W. Tarr, Nicasio Mancini, Massimo Clementi, Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  7. 7
    Guillaume Desoubeaux, Arnaud Daguet, Hervé Watier, Therapeutic antibodies and infectious diseases, Tours, France, November 20−22, 2012, mAbs, 2013, 5, 5, 626

    CrossRef

  8. 8
    Carrie Enever, Edward Coulstock, Malgorzata Pupecka-Swider, Bruce Hamilton, Single-Domain Antibodies: An Overview,